Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00601237 · ClinicalTrials.gov registry record · NA

Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk Prevention

A NA study of HIV Infections, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
103
Enrollment target
1
Study location

NCT00601237 is a NA study of HIV Infections that has completed, run by University of Colorado, Denver. The registered enrollment target is 103 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00601237, a NA study of HIV Infections, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
103 participants
Enrollment target
1
Study location

Study Summary

This study will develop and test the effectiveness of a cell phone-based text messaging program to encourage abstinence, monogamy, or condom use among black urban males in Philadelphia, Pennsylvania.

Conditions Studied

Interventions

  • BEHAVIORAL HIV-related text messaging
  • BEHAVIORAL Nutrition-related text messaging

Study Locations (1)

Pennsylvania

  • Motivational Educational Entertainment (MEE) Productions - Philadelphia

Trial Details

FieldValue
Enrollment Target 103 participants
Start Date 2008-10
Est. Completion 2013-05
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT00601237

The ClinicalTrials.gov registry entry for NCT00601237 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (77% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which HIV-related text messaging is the first listed.

NCT00601237 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00601237 about?

NCT00601237 is a clinical study titled "Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk Prevention". This study will develop and test the effectiveness of a cell phone-based text messaging program to encourage abstinence, monogamy, or condom use among black urban males in Philadelphia, Pennsylvania.

What is the current status of trial NCT00601237?

This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2008-10. Estimated completion is 2013-05.

What conditions does trial NCT00601237 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00601237?

The interventions under investigation include: HIV-related text messaging (BEHAVIORAL), Nutrition-related text messaging (BEHAVIORAL).

Who is sponsoring clinical trial NCT00601237?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00601237 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.